Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20221108056446N14Phase 2Completed
Phase 2 trial of promethazine and betahistine in vertigo (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Speed of improvement in peripheral vertigo symptoms and Severity of improvement in peripheral vertigo symptoms. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20221108056446N14.